Allan Lanzon

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

R. Moots, P. Emery, D. Mevorach, 2017, The Lancet.

Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study

P. Miranda, W. Park, A. Baranauskaitė, 2016, Annals of the rheumatic diseases.

Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines

J. Li-Yu, L. Llamado, E. C. Perez, 2011, International journal of rheumatic diseases.

Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines

J. Li-Yu, L. Llamado, E. C. Perez, 2011, International journal of rheumatic diseases.